N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester | CAS:1452466-39-5

We serve N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester CAS:1452466-39-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester

Chemical Name:N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester
CAS.NO:1452466-39-5
Synonyms:N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester
2-Methyl-2-propanyl {[2-(aminooxy)ethyl]sulfamoyl}carbamate
Carbamic acid, N-[[[2-(aminooxy)ethyl]amino]sulfonyl]-, 1,1-dimethylethyl ester
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Molecular Formula C7H17N3O5S
Molecular Weight 255.292
Index of Refraction 1.501
 
Specification:
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Avibactam(CAS:1192491-61-4).



Contact us for information like N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carbamic acid, N-[[[2-(aminooxy)ethyl]amino]sulfonyl]-, 1,1-dimethylethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbamic acid, N-[[[2-(aminooxy)ethyl]amino]sulfonyl]-, 1,1-dimethylethyl ester Use and application,Carbamic acid, N-[[[2-(aminooxy)ethyl]amino]sulfonyl]-, 1,1-dimethylethyl ester technical grade,usp/ep/jp grade.


Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.Propionyl bromide manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).2-(5-chloro-2H-indazol-3-yl)acetic acid supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Trifluoroacetic acid pentafluorophenyl ester vendor Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.